Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Da Prada

Showing results (171-180 of 175) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 175 results.
Psychopharmacology|January 1, 1992
Biochemistry and pharmacology of moclobemide, a prototype RIMAW Haefely, W P Burkard, A M Cesura, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1989
Pharmacological profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type AW P Burkard, E P Bonetti, M Da Prada, et al.
Journal of Neural Transmission. Supplementum|January 1, 1990
From moclobemide to Ro 19-6327 and Ro 41-1049: the development of a new class of reversible, selective MAO-A and MAO-B inhibitorsM Da Prada, R Kettler, H H Keller, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Measurement of human cerebral monoamine oxidase type B (MAO-B) activity with positron emission tomography (PET): a dose ranging study with the reversible inhibitor Ro 19-6327C J Bench, G W Price, A A Lammertsma, et al.
Arzneimittel-Forschung|January 1, 1981
Pharmacology of midazolamL Pieri, R Schaffner, R Scherschlicht, et al.
Pageof 18

Showing results (171-180 of 175) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 175 results.
Psychopharmacology|January 1, 1992
Biochemistry and pharmacology of moclobemide, a prototype RIMAW Haefely, W P Burkard, A M Cesura, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1989
Pharmacological profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type AW P Burkard, E P Bonetti, M Da Prada, et al.
Journal of Neural Transmission. Supplementum|January 1, 1990
From moclobemide to Ro 19-6327 and Ro 41-1049: the development of a new class of reversible, selective MAO-A and MAO-B inhibitorsM Da Prada, R Kettler, H H Keller, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Measurement of human cerebral monoamine oxidase type B (MAO-B) activity with positron emission tomography (PET): a dose ranging study with the reversible inhibitor Ro 19-6327C J Bench, G W Price, A A Lammertsma, et al.
Arzneimittel-Forschung|January 1, 1981
Pharmacology of midazolamL Pieri, R Schaffner, R Scherschlicht, et al.
Pageof 18